Cargando…
Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma
SIMPLE SUMMARY: Cancer-associated fibroblasts (CAFs) are highly prevalent cells in the clear cell renal cell carcinoma (ccRCC) tumor immune microenvironment. CAFs are thought to potentiate tumor proliferation primarily through paracrine interactions, as evidenced by laboratory-based studies. We soug...
Autores principales: | Chakiryan, Nicholas H., Kimmel, Gregory J., Kim, Youngchul, Johnson, Joseph O., Clark, Noel, Hajiran, Ali, Chang, Andrew, Aydin, Ahmet M., Zemp, Logan, Katende, Esther, Chahoud, Jad, Ferrall-Fairbanks, Meghan C., Spiess, Philippe E., Francis, Natasha, Fournier, Michelle, Dhillon, Jasreman, Park, Jong Y., Wang, Liang, Mulé, James J., Altrock, Philipp M., Manley, Brandon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345222/ https://www.ncbi.nlm.nih.gov/pubmed/34359645 http://dx.doi.org/10.3390/cancers13153743 |
Ejemplares similares
-
Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021) -
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma
por: Chakiryan, Nicholas H, et al.
Publicado: (2023) -
Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Ferrall-Fairbanks, Meghan C., et al.
Publicado: (2022) -
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021) -
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021)